More Healthcare Coverage

Expert Analysis

• Legal Pitfalls To Watch For When Advertising Psychedelics

  

  As psychedelic products and related therapeutic services make their way into the mainstream, companies engaged in creating or publishing ads for such products and services should consider several legal implications on federal, state and local levels, says Dorian Thomas at Frankfurt Kurnit.

• ERISA Ruling Shows Why Insurers Must Justify Claim Denials

  

  The Tenth Circuit's recent decision in D.K. v. United Behavioral Health imposed a long-overdue measure of accountability on health insurers by holding that Employee Retirement Income Security Act compliance requires responding to the medical opinions of the beneficiary's treating doctors before denying claims, says Mark DeBofsky at DeBofsky Law.

• USDA Salmonella Proposal Propels New Food Safety Journey

  

  The U.S. Department of Agriculture's recent proposed policy to declare salmonella an adulterant in breaded stuffed raw chicken products could have major implications not only for the specialized products at issue, but also the entire poultry industry and beyond, say Bob Hibbert and Amaru Sanchez at Wiley.

• What The Justices' Questions Signify For FCA Compliance

  

  Whatever the outcome of two False Claims Act cases pending before the U.S. Supreme Court, the justices' questions during recent oral arguments indicate that government contractors should take certain steps to ensure their compliance programs are demonstrably active and adaptable, say Holly Butler and Rebecca Fallk at Miles & Stockbridge.

• What Texas Misrepresentation Ruling Means For Insurers

  

  The Texas Supreme Court's recent decision in American National Insurance v. Arce, confirming that insurers must prove intent to deceive in order to rescind coverage based on material misrepresentation, solidifies additional burdens for insurers to consider during both the underwriting and claims adjudication processes, say Josh Pedelty and Javon Johnson at Husch Blackwell.

• What FTC's Data Actions Say About Tracker Enforcement

  

  The Federal Trade Commission’s recent enforcement actions against GoodRx and BetterHelp for sharing sensitive user information show the agency may be setting a new standard for the collection, use and disclosure of user data, which should prompt companies to audit their use of — and policies regarding — data trackers, says Reed Freeman at ArentFox Schiff.

• Labor Collusion Loss Will Shape DOJ's Case Strategy

  

  Following the U.S. Department of Justice’s recent loss in United States v. Manahe, tallying its trial score record to 0-3 in labor-related antitrust cases over the past year, defendants can expect that the DOJ will try to exclude defense evidence and argue for more favorable jury instructions, say attorneys at Sheppard Mullin.

• Examining Chancery's Recent Openness To Caremark Claims

  

  As seen in an April decision involving Walmart's role in the national opioid epidemic, the Delaware Chancery Court has recently shown receptivity to Caremark claims at the early pleading stage of litigation, providing plaintiffs with more leverage to negotiate an early settlement and bringing risk management lessons for boards, say attorneys at Fried Frank.

• Expect The Patchwork Of AI Regulation To Grow

  

  Given the unlikelihood of meaningful federal artificial intelligence legislation in the immediate future, the patchwork of state AI regulation will likely continue to grow, bringing at least two main risks for companies in the AI space, say attorneys at Jenner & Block.

• Job Reassignment Case Shows Need For Clear ADA Policies

  

  The Fifth Circuit's recent holding in U.S. Equal Employment Opportunity Commission v. Methodist Hospitals that a disabled employee was not entitled to a job reassignment as a reasonable accommodation underscores the importance of implementing detailed Americans with Disabilities Act policies and educating employees on them, says Marcellus Chamberlain at Phelps Dunbar.

• White Collar Defense Lessons From The Bench And Beyond

  

  Former Minnesota judge and federal prosecutor Nicole Engisch, now a partner at Dorsey & Whitney, shares insights from her background that may inform attorneys’ defense-side approach in white collar cases and corporate investigations — more relevant than ever given the U.S. Department of Justice’s recent policy changes.

• Comparing Iowa's Data Privacy Law With Other States'

  

  Iowa’s recently signed data privacy law is intentionally more business-friendly than other U.S. state privacy laws — as it does not apply in the business-to-business contexts and does not have a private right of action — and further entrenches the main tenets of enhanced privacy in the U.S., say attorneys at Eversheds Sutherland.

• Ga. Needs To Resolve Cannabis Counsel Confusion

  

  Georgia’s medical cannabis regulator finally adopted rules for low-THC oil last month, but a 2021 ethics ruling prohibits lawyers from advising participants in the state’s legal program and creates a confounding landscape that the state bar and courts must address, say Whitt Steineker and Mason Kruze at Bradley Arant.